Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003559245 | SCV004278695 | pathogenic | not provided | 2022-12-14 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser303Cysfs*76) in the FAM20A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAM20A are known to be pathogenic (PMID: 21990045, 23434854). This variant is present in population databases (rs750880244, gnomAD 0.02%). This premature translational stop signal has been observed in individual(s) with FAM20A-related conditions (PMID: 23434854). It has also been observed to segregate with disease in related individuals. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005014750 | SCV005651037 | pathogenic | Amelogenesis imperfecta type 1G | 2024-04-05 | criteria provided, single submitter | clinical testing |